Progenicyte

Progenicyte is a biotechnology company focused on the development of regenerative medicine and stem cell-based therapies. The company utilizes a proprietary platform to isolate and differentiate stem cells for the treatment of various degenerative conditions, including neurological disorders and organ failure. Their research emphasizes the use of autologous and allogeneic cell sources to restore function in damaged tissues. Progenicyte aims to bridge the gap between laboratory discovery and clinical application through innovative cell engineering. The company's pipeline includes programs targeting Alzheimer's, Parkinson's, and spinal cord injuries.